peptide database · 12 graded compounds · 9 measured in people
peptides for fat loss & metabolism: what the research shows
12 graded compounds were studied for fat & metabolism, 9 of them in people. Each is graded A to F on published evidence; the ladder shows how far research got, from cell studies to approval.
selected systemclick a lit region to explore itdrag to rotate
- Liraglutidemeasured in people$10.20/mg
- Semaglutidemeasured in people$6.00/mg
- Tesamorelinmeasured in people$7.50/mg
- Tirzepatidemeasured in people$3.50/mg
- Cagrilintidemeasured in people$10.00/mg
- Mazdutidemeasured in people
- Retatrutidemeasured in people$6.25/mg
- Survodutidemeasured in people
- 5-Amino-1MQanimal or cell studies$1.20/mg
- MOTS-canimal or cell studies$3.50/mg
- SLU-PP-332animal or cell studies$15.00/mg
- AOD-9604measured in people$5.00/mg
3D anatomy: Human Reference Atlas reference organs from the NIH Visible Human Project (CC BY 4.0) and BodyParts3D, © The Database Center for Life Science (CC BY-SA 2.1 JP), fitted to each body and simplified by PeptideTech; the adapted BodyParts3D meshes are shared under the same licence. Lymph node clusters, the thyroid, joint capsules and the fat layer are drawn for orientation.
research market · not for human use
A lit region shows where studies measured an effect, not that a compound works there. Most research-market compounds are not FDA-approved.
Evidence grades come from the published literature; no vendor can pay for a grade or a ranking. Some outbound links are affiliate links; they never affect grades, scores or order.
fat & metabolism
evidence table
| compound | grade | highest rung | US status | body systems | from $/mg | studies |
|---|---|---|---|---|---|---|
| Liraglutide GLP-1 agonist | approved somewhere | FDA-approved | fat & metabolismgutheart | $10.20 | research profile | |
| Semaglutide GLP-1 agonist | approved somewhere | FDA-approved | fat & metabolismgutheartkidneysliver | $6.00 | research profile | |
| Tesamorelin GHRH analogue | approved somewhere | FDA-approved | hormone axisfat & metabolismliver | $7.50 | research profile | |
| Tirzepatide GIP/GLP-1 dual agonist | approved somewhere | FDA-approved | fat & metabolismgutliverheartlungs & airway | $3.50 | research profile | |
| Cagrilintide long-acting amylin analogue | phase 3 trial | investigational | fat & metabolismgutbrain & mood | $10.00 | research profile | |
| Mazdutide glucagon/GLP-1 dual agonist | phase 3 trial | investigational | fat & metabolismliver | — | research profile | |
| Retatrutide GIP/GLP-1/glucagon triple agonist | phase 2 trial | investigational | fat & metabolismlivergut | $6.25 | research profile | |
| Survodutide glucagon/GLP-1 dual agonist | phase 2 trial | investigational | fat & metabolismliver | — | research profile | |
| 5-Amino-1MQ NNMT inhibitor | animal studies | research only | fat & metabolismmuscle | $1.20 | research profile | |
| MOTS-c mitochondrial-derived peptide | animal studies | rulemaking pending | musclefat & metabolism | $3.50 | research profile | |
| SLU-PP-332 ERR agonist | animal studies | research only | musclefat & metabolism | $15.00 | research profile | |
| AOD-9604 hGH fragment 177–191 | phase 2 trial | compounding restricted | fat & metabolism | $5.00 | research profile |
short answers
questions about peptides for fat loss & metabolism
Which peptides have been studied for fat loss & metabolism?
12 graded compounds: Liraglutide (A), Semaglutide (A), Tesamorelin (A), Tirzepatide (A), Cagrilintide (B), Mazdutide (B), Retatrutide (B), Survodutide (B), 5-Amino-1MQ (D), MOTS-c (D), SLU-PP-332 (D), AOD-9604 (F). Grades run from A (approved, strong human outcome data) to F (contradicted, unsafe, or identity problems).
Which peptides for fat loss & metabolism were measured in people?
9 of 12: Liraglutide, Semaglutide, Tesamorelin, Tirzepatide, Cagrilintide, Mazdutide, Retatrutide, Survodutide and AOD-9604. The others have animal or cell studies only for fat & metabolism.
Which peptide has the strongest evidence for fat loss & metabolism?
Liraglutide: grade A, highest rung approved somewhere. Approved for type 2 diabetes and weight management, with cardiovascular outcome data.
What does a lit region on the body map mean?
That published studies measured an effect there. Mint means it was measured in people; periwinkle means animals or cells only. A lit region is not a claim that a compound works there.
Is this medical advice?
No. PeptideTech is an independent information service. Research-market compounds are sold as research chemicals and most are not approved for use in people.